These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7523271)

  • 1. Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients.
    Kanazawa Y; Hayashi N; Mita E; Li T; Hagiwara H; Kasahara A; Fusamoto H; Kamada T
    Hepatology; 1994 Nov; 20(5):1121-30. PubMed ID: 7523271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy.
    Shindo M; Hamada K; Koya S; Arai K; Sokawa Y; Okuno T
    Hepatology; 1996 Nov; 24(5):1018-23. PubMed ID: 8903369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment.
    Koizumi K; Enomoto N; Kurosaki M; Murakami T; Izumi N; Marumo F; Sato C
    Hepatology; 1995 Jul; 22(1):30-5. PubMed ID: 7541387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.
    Pawlotsky JM; Pellerin M; Bouvier M; Roudot-Thoraval F; Germanidis G; Bastie A; Darthuy F; Rémiré J; Soussy CJ; Dhumeaux D
    J Med Virol; 1998 Apr; 54(4):256-64. PubMed ID: 9557291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C viral quasispecies in hepatitis C virus carriers with normal liver enzymes and patients with type C chronic liver disease.
    Naito M; Hayashi N; Moribe T; Hagiwara H; Mita E; Kanazawa Y; Kasahara A; Fusamoto H; Kamada T
    Hepatology; 1995 Aug; 22(2):407-12. PubMed ID: 7635407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleotide sequence variations in the internal ribosome entry site of hepatitis C virus-1b: no association with efficacy of interferon therapy or serum HCV-RNA levels.
    Yamamoto C; Enomoto N; Kurosaki M; Yu SH; Tazawa J; Izumi N; Marumo F; Sato C
    Hepatology; 1997 Dec; 26(6):1616-20. PubMed ID: 9398006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypervariable region sequence in cryoglobulin-associated hepatitis C virus in sera of patients with chronic hepatitis C: relationship to antibody response against hypervariable region genome.
    Aiyama T; Yoshioka K; Okumura A; Takayanagi M; Iwata K; Ishikawa T; Kakumu S
    Hepatology; 1996 Dec; 24(6):1346-50. PubMed ID: 8938159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C.
    González-Peralta RP; Qian K; She JY; Davis GL; Ohno T; Mizokami M; Lau JY
    J Med Virol; 1996 Jul; 49(3):242-7. PubMed ID: 8818972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection.
    Kurosaki M; Enomoto N; Marumo F; Sato C
    Hepatology; 1993 Dec; 18(6):1293-9. PubMed ID: 8244252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleotide sequence variation in the hypervariable region of the hepatitis C virus in the sera of chronic hepatitis C patients undergoing controlled interferon-alpha therapy.
    Yeh BI; Han KH; Oh SH; Kim HS; Hong SH; Oh SH; Kim YS
    J Med Virol; 1996 Jun; 49(2):95-102. PubMed ID: 8991943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inferred hepatitis C virus quasispecies diversity is influenced by choice of DNA polymerase in reverse transcriptase-polymerase chain reactions.
    Mullan B; Kenny-Walsh E; Collins JK; Shanahan F; Fanning LJ
    Anal Biochem; 2001 Feb; 289(2):137-46. PubMed ID: 11161307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degree of diversity of hepatitis C virus quasispecies and progression of liver disease.
    Honda M; Kaneko S; Sakai A; Unoura M; Murakami S; Kobayashi K
    Hepatology; 1994 Nov; 20(5):1144-51. PubMed ID: 7927245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity in E2 region of GBV-C/hepatitis G virus and hepatitis C virus.
    Kato T; Mizokami M; Nakano T; Orito E; Ohba K; Kondo Y; Tanaka Y; Ueda R; Mukaide M; Fujita K; Yasuda K; Iino S
    J Med Virol; 1998 Jun; 55(2):109-17. PubMed ID: 9598930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between diversity of hepatitis C virus quasispecies and viremia, activity of liver disease and response to interferon therapy].
    Tang X; Qian K; Yuan X; Johnson YN
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):128-31. PubMed ID: 12196822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of disease activity during chronic hepatitis C infection to complexity of hypervariable region 1 quasispecies.
    Yuki N; Hayashi N; Moribe T; Matsushita Y; Tabata T; Inoue T; Kanazawa Y; Ohkawa K; Kasahara A; Fusamoto H; Kamada T
    Hepatology; 1997 Feb; 25(2):439-44. PubMed ID: 9021961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mode of HCV infection examined by polymorphism of hypervariable region-1 in cases of acute hepatitis C after accidental exposure to blood-borne pathogens.
    Takeda T; Tatsumi N; Nakayama Y; Yasuda T; Nishiguchi S; Seki S
    J Med Virol; 2005 Jan; 75(1):35-41. PubMed ID: 15543585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection.
    Chayama K; Tsubota A; Kobayashi M; Okamoto K; Hashimoto M; Miyano Y; Koike H; Kobayashi M; Koida I; Arase Y; Saitoh S; Suzuki Y; Murashima N; Ikeda K; Kumada H
    Hepatology; 1997 Mar; 25(3):745-9. PubMed ID: 9049229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution and selection of hepatitis C virus variants in patients with chronic hepatitis C.
    Kurosaki M; Enomoto N; Marumo F; Sato C
    Virology; 1994 Nov; 205(1):161-9. PubMed ID: 7975211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complexity of the HVR-1 quasispecies and disease activity in patients with hepatitis C.
    Kumagai N; Kaneko F; Tsunematsu S; Tsuchimoto K; Tada S; Saito H; Hibi T
    Eur J Clin Invest; 2007 Jul; 37(7):566-72. PubMed ID: 17576208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C.
    Oshita M; Hayashi N; Kasahara A; Hagiwara H; Mita E; Naito M; Katayama K; Fusamoto H; Kamada T
    Hepatology; 1994 Nov; 20(5):1115-20. PubMed ID: 7523270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.